Concepedia

Author

Ana Lucia Relo

AbbVie (Germany)

Also Known As

A. L. Rêlo, Ana L. Relo, Ana L. Rêlo, Ana Lucia Relo, Ana Relo

9

Publications

156

Citations

6

H-Index

32

Concepts

All Affiliations

AbbVie (Germany)AbbVie (United States)
AL

About

Ana Lucia Relo is an author at AbbVie (Germany) specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

82

2

Natural Sciences

2

2

57

3

Biochemistry

2

2

57

4

Social Sciences

1

1

20

5

Chemical Biology

1

1

23

Ana Lucia Relo

×

6

Publications

153

Citations

6

H-Index

YearCitations

Towards trans-diagnostic mechanisms in psychiatry: Neurobehavioral profile of rats with a loss of function point mutation in the dopamine transporter gene

Valentina Vengeliene, Anton Bespalov, Martin Roßmanith,

Disease Models & Mechanisms

2017

36

Discovery of Novel and Highly Selective Inhibitors of Calpain for the Treatment of Alzheimer’s Disease: 2-(3-Phenyl-1<i>H</i>-pyrazol-1-yl)-nicotinamides

Andreas Kling, Katja Jantos, Helmut Mack,

Journal of Medicinal Chemistry

2017

34

Quantitative Systems Pharmacology Model for Alzheimer Disease Indicates Targeting Sphingolipid Dysregulation as Potential Treatment Option

Diana Clausznitzer, César Pichardo‐Almarza, Ana Lucia Relo,

CPT Pharmacometrics & Systems Pharmacology

2018

25

De Novo Design, Synthesis, and Biological Evaluation of 3,4-Disubstituted Pyrrolidine Sulfonamides as Potent and Selective Glycine Transporter 1 Competitive Inhibitors

Ying Wang, Hongyu Zhao, J.T. Brewer,

Journal of Medicinal Chemistry

2018

23

NOGO-66 receptor deficient mice show slow acquisition of spatial memory task performance

Marcel M. van Gaalen, Ana Lucia Relo, Bernhard K. Mueller,

Neuroscience Letters

2012

20

Discovery of Novel Aminotetralines and Aminochromanes as Selective and Competitive Glycine Transporter 1 (GlyT1) Inhibitors

Willi Amberg, Udo E. W. Lange, Michael Ochse,

Journal of Medicinal Chemistry

2018

15

Page 1